Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Boehringer Ingelheim
Express Scripts
Farmers Insurance
Johnson and Johnson

Generated: November 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,472,380

« Back to Dashboard

Summary for Patent: 4,472,380

Title: Amino acid derivatives as antihypertensives
Abstract:There are disclosed processes for preparing carboxyalkyl dipeptide derivatives and related compounds which are useful as angiotension converting enzyme (ACE) inhibitors and as antihypertensives and pharmaceutical compositions containing these carboxyalkyl dipeptide compounds in combination with another antihypertensive and/or diuretic compound.
Inventor(s): Harris; Elbert E. (Westfield, NJ), Patchett; Arthur A. (Westfield, NJ), Tristram; Edward W. (Watchung, NJ), Wyvratt; Matthew J. (Mountainside, NJ)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:06/423,916
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Process;

No matches for this query

International Patent Family for Patent: 4,472,380

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Israel58849► Subscribe
JapanS5581845► Subscribe
JapanH032878► Subscribe
JapanH02131496► Subscribe
Spain494300► Subscribe
Spain8106134► Subscribe
Finland793799► Subscribe
Finland68405► Subscribe
Greece72251► Subscribe
Hong Kong27487► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus